AIMS: To establish all-cause mortality rates, and risk factors for mortality in insulin-treated diabetic individuals living in Canterbury, New Zealand. METHODS: Insulin-treated diabetic subjects (n=995) on the Canterbury Diabetes Registry were followed up over 20-year and vital status determined. Death rates were standardised and hazard regression was used to model the effects of demographic covariates on relative survival time. RESULTS: Six subjects had emigrated, the remaining 989 diabetic subjects contributed a total of 13705.53 person-years of follow-up, a mean of 13.7 years per subject. During follow-up 525 deaths occurred in subjects' aged 17.3-96.7, (261 females, 264 males). All-cause mortality rates in diabetic subjects exceeded those in the general population at all ages. SMRs were slightly higher for females than males in almost all age-at-onset groups, being 2.48 (95% CI: 2.18-2.78) for females and 2.17 (95% CI: 1.91-2.43) for males overall, but reaching a peak in the <30 age at onset group for both females and males being 4.25 (3.07-5.44) and 3.26 (2.49-4.03), respectively. CONCLUSIONS: Mortality rates for diabetic individuals remain high, resulting in shortened life spans relative to the general population. This study provides a baseline for further studies of mortality and changes in mortality within New Zealand.
AIMS: To establish all-cause mortality rates, and risk factors for mortality in insulin-treated diabetic individuals living in Canterbury, New Zealand. METHODS:Insulin-treated diabetic subjects (n=995) on the Canterbury Diabetes Registry were followed up over 20-year and vital status determined. Death rates were standardised and hazard regression was used to model the effects of demographic covariates on relative survival time. RESULTS: Six subjects had emigrated, the remaining 989 diabetic subjects contributed a total of 13705.53 person-years of follow-up, a mean of 13.7 years per subject. During follow-up 525 deaths occurred in subjects' aged 17.3-96.7, (261 females, 264 males). All-cause mortality rates in diabetic subjects exceeded those in the general population at all ages. SMRs were slightly higher for females than males in almost all age-at-onset groups, being 2.48 (95% CI: 2.18-2.78) for females and 2.17 (95% CI: 1.91-2.43) for males overall, but reaching a peak in the <30 age at onset group for both females and males being 4.25 (3.07-5.44) and 3.26 (2.49-4.03), respectively. CONCLUSIONS: Mortality rates for diabetic individuals remain high, resulting in shortened life spans relative to the general population. This study provides a baseline for further studies of mortality and changes in mortality within New Zealand.
Authors: Aaron M Secrest; Dorothy J Becker; Sheryl F Kelsey; Ronald E LaPorte; Trevor J Orchard Journal: Diabetes Care Date: 2010-12 Impact factor: 19.112